Linda Soo Hoo, PhD, is a manager of Technical Services at Gilead Sciences working at the La Verne and San Dimas parental manufacturing facilities. She has over 7 years of industrial experience in various aspects of biopharmaceutical manufacturing, including CMC regulatory submissions, technology transfer of clinical products, development and validation of analytical methods, nanotechnology regulations and liposome technology. She received her Ph.D. from the University of California at Santa Barbara in Molecular, Cellular, and Developmental Biology and a post-doctoral fellowship from NIH at UCLA working on biomarker discovery. She is an alumnus of the Post-doctoral Professional Masters in Bioscience Management at Keck Graduate Institute in Claremont, CA. She has spoken at public events on topics of career development and various aspects of nanotechnology regulations. She has authored book and journal publications on nanotechnologies. She currently holds a Regulatory Affairs Certification, RAC (US). She is a current member of AAPS, ISPE, and PDA and currently an active executive committee member of the Southern California Pharmaceutical Discussion Group (SCPDG) which hosts educational seminars to foster education in and knowledge of the pharmaceutical sciences, its industry and regulations.